News

Packaging of the bottle does not comply with the requirements of the Poison Prevention Packaging Act. The dietary supplement bottles contain 90 tablets of 25mg iron supplement each,

As per the definitive agreement signed between both the parties, AstraZeneca will acquire Pearl’s shares for initial consideration of $560m that is payable on completion of the transaction.

The approval will allow the use of Rienso in all adult iron deficiency anemia patients who cannot take oral iron, in addition to current indication for the treatment

Around 600 patients are expected be enrolled in the study and will be randomized with PB272 plus Xeloda or Tykerb plus Xeloda. Puma Biotechnology chief executive officer and

Pharmavite chief operating officer Mark Walsh said, "At 330,000 square feet, the Opelika-based Pharmavite facility is one of the largest vitamin, mineral and supplement (VMS) manufacturing facilities built

Conducted in 56 patients with hypercholesterolemia and a history of intolerance to two or more statins, the study demonstrated considerable tolerability profile of the investigational candidate. Following an

Indicated for people with body mass index (BMI) of 30kg/m2 or more, or BMI of 27kg/m2 or more and coupled with a minimum of one weight-related medical condition

The investigational product is an oral nucleotide analogue inhibitor to be administered once each day with the safety and efficacy profile yet to be evaluated. Under the Prescription

Backed by PA Consulting-developed social media analysis software, the patient recruitment program will enable users’ to access new information about potential patients, including mapping the geographical distribution of